Table 1. Clinical characteristics of subjects.
| Characteristic | N (%)/Mean ± SD |
|---|---|
| Gender | |
| Male | 135 (39.8) |
| Female | 204 (60.2) |
| Age (years) | 38.7 ± 11.53 |
| Duration of illness (years) | 9.31 ± 8.67 |
| First-episode patients (FEPs) | 86 (25.4) |
| BMI at baseline | 23.42 ± 4.10 |
| WHR at baseline | 0.88 ± 0.06 |
| Medication | |
| Olanzapine | 131 (38.6) |
| Risperidone | 133 (39.2) |
| Clozapine | 23 (6.8) |
| Quetiapine | 27 (8.0) |
| Aripiprazole | 14 (4.1) |
| Ziprasidone | 11 (3.2) |
Abbreviations: BMI, body mass index; WHR, Waist -Hip Ratio.